Long Term Pharmacotherapy for Alcohol Use Disorder

Authors

  • Indranil Saha 1Associate Professor, Institute of Psychiatry – A Centre of Excellence, IPGMER & SSKM Hospital, Kolkata
  • Supartha Barua Assistant Professor, Institute of Psychiatry – A Centre of Excellence, IPGMER & SSKM Hospital, Kolkata
  • Arijit Mondal Senior Resident, Institute of Psychiatry – A Centre of Excellence, IPGMER & SSKM Hospital, Kolkata

DOI:

https://doi.org/10.51332/bjp.2020.v25.i1.80

Abstract

The psychopharmacology of alcohol dependence is today poised at interesting crossroads. Three major drugs Naltrexone, Disulfiram and Acamprosate have been tried and tested in various trials and have many meta-analyses each to support them. While Naltrexone may reduce craving, Acamprosate scores on cost effectiveness worldwide with Disulfiram being an alcohol deterrent drug. Studies support, refute and criticize the use of each of these drugs. Combining one or more of them is also a trend seen. The most important factor in efficacy has been the combination of psychosocial treatment with medication. In this article, we are going to discuss about long term pharmacological management of chronic alcoholism.

Downloads

Published

2020-10-24

Issue

Section

Review Articles